THU-142-Sofosbuvir + velpatasvir + voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program

Autor:	Luminita Bonyhay, Jean-Pierre Bronowicki, Vincent Di Martino, Christophe Hézode, Jean-Pierre Arpurt, Anne Minello Franza, Kerstin Hartig, Christophe Pilette, Erard Domitille, Véronique Grando, Dominique Larrey, Jean-Marc Combis, Eric Nguyen-Khac, N. Giuily, Valérie Canva, Dominique Guyader, Laurent Cotte, Christophe Zamora, Saadi Mokhtari, Marc-Antoine Valantin, Michel Antoni, Régine Truchi, Yvon Calmus, Christophe Renou, Marc Bourlière, D. Ribard
Rok vydání:	2019
Předmět:	medicine.medical_specialty Cirrhosis Hepatology business.industry medicine Compassionate Use Intensive care medicine medicine.disease business Sofosbuvir / velpatasvir / voxilaprevir
Zdroj:	Journal of Hepatology. 70:e224
ISSN:	0168-8278
DOI:	10.1016/s0618-8278(19)30417-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0253734b074431e86d947cbbad479fd8 https://doi.org/10.1016/s0618-8278(19)30417-7 Zobrazit plný text záznamu Full Text from ScienceDirect